Lipid-Coated Biodegradable Particles as "Synthetic Pathogens" for Vaccine Engineering
Name
Bershteyn-2009-Lipid-Coated Biodegradable Particles as Synthetic Pathogens for Vaccine Engineering.pdf
Size
2.21 MB
Format
Adobe PDF
Checksum (MD5)
89d2cdd2ab0de44964bb34212b2122b7
Author(s)
Chaparro, Jose P.
Bershteyn, Anna
Riley, E. B.
Yao, R. S.
Zachariah, Roshini Sarah
Irvine, Darrell J.
Date Issued
May 2009
Journal
2009 IEEE 35th Annual Northeast Bioengineering Conference
Publisher
Institute of Electrical and Electronics Engineers
Citation
Bershteyn, A. et al. “Lipid-coated biodegradable particles as “synthetic pathogens” for vaccine engineering.” Bioengineering Conference, 2009 IEEE 35th Annual Northeast. 2009. 1-2. ©2009 Institute of Electrical and Electronics Engineers.
Version
Final published version
Abstract
The physicochemical context in which molecules are presented at the surfaces of microbes has tremendous implications for the immune response to vaccination. The spacing and mobility of molecules may control interactions of their receptors, influencing immune cell activation, pathogen uptake, and antigen processing. The chemical environment of antigens also influences the specificity of the humoral immune response, because antibodies recognize antigen in its three-dimensional shape and context. Finally, physical properties of antigen, such as diameter, impact immune response on both a cellular and tissue level. We have constructed ldquosynthetic pathogensrdquo consisting of a biodegradable core polymer coated by a lipid shell to mimic a bilayer-enveloped pathogen. Synthesized in an oil-in-water emulsion, these particles have an average diameter on the order of either 100 nm, mimicking a lipid-enveloped viral pathogen, or 1 micron, mimicking a bacterial pathogen. CryoEM reveals self-assembled lipid layers at the particle surface. With tunable chemical and physical properties, these particles can be used to study the importance of specific properties of biomaterials when used in vaccination. Because all components are biodegradable, the particles may provide a clinically applicable way of implementing structural features of microbes in synthetic vaccines.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Materials Science and Engineering
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1109/NEBC.2009.4967679
